#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Mitomycin-C with Electromotive Drug Administration before Surgery in Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Hungary Italy +3

  • Study on Avelumab for Patients with Advanced Urothelial Cancer After Initial Chemotherapy

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of N-803 combined with BCG treatment for patients with early-stage bladder cancer that has not invaded the muscle wall

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany

  • Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium France Germany The Netherlands Poland +1

  • Study on the Safety and Effectiveness of Alpha1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

    Not recruiting

    1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark France Germany Italy The Netherlands Poland +1

  • Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study of Durvalumab and Tremelimumab for Patients with Advanced Unresectable Urothelial Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece Spain